David Larsen Analyst Performance

Managing Director at BTIG Research

David Larsen is a stock analyst at BTIG Research focused in the medical sector, covering 26 publicly traded companies. Over the past year, David Larsen has issued 8 stock ratings, including buy and hold recommendations. While full access to David Larsen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Larsen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 131 Last 10 Years
Buy Recommendations: 59.69% 77 Buy Ratings
Companies Covered: 26 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	59.7%	77 ratings
Hold	40.3%	52 ratings
Sell	0.0%	0 ratings

Out of 129 total stock ratings issued by David Larsen at BTIG Research, the majority (59.7%) have been Buy recommendations, followed by 40.3% Hold.

Best & Worst Calls

Best Call
000.0%
EVH
Mar 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
DPLO
Jun 2018
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	61.5% of companies on NASDAQ	16 companies
NYSE	38.5% of companies on NYSE	10 companies

David Larsen, an analyst at BTIG Research, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	69.2%
	Computer and Technology 3 companies	11.5%
	Miscellaneous 2 companies	7.7%
	Transportation 1 company	3.8%
	Retail/Wholesale 1 company	3.8%
	Business Services 1 company	3.8%

David Larsen of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 4 companies	15.4%
MEDICAL SERVICES 4 companies	15.4%
MED/DENTAL - SUPP 3 companies	11.5%
COMPUTER INTEGRATED SYSTEMS DESIGN 3 companies	11.5%
CUSTOM COMPUTER PROGRAMMING SERVICES 2 companies	7.7%
DRUG STORES & PROPRIETARY STORES 2 companies	7.7%
TRANS - SERVICES 1 company	3.8%
INTERNET SOFTWARE 1 company	3.8%
COMP - SOFTWARE 1 company	3.8%
HEALTH SERVICES 1 company	3.8%
COMMUNICATION EQUIPMENT 1 company	3.8%
HOLDING & OTHER INVESTMENT OFFICES 1 company	3.8%
MED PRODUCTS 1 company	3.8%
Miscellaneous 1 company	3.8%

About David Larsen

David Larsen, Managing Director, is a BTIG Healthcare IT and Digital Health Analyst. Prior to BTIG, Mr. Larsen was the Founder and Senior Analyst in Healthcare IT and Digital Health at Verity Research. Previously as Managing Director, he was a Senior Analyst in Healthcare IT and Distribution Research at SVB Leerink, where he spent more than a decade. Earlier in his career, Mr. Larsen was an Associate Analyst within Healthcare Services at Cowen and Company and SunTrust Robinson Humphrey. He was also a Senior Consultant within the Healthcare Practice at PricewaterhouseCoopers and a Senior Financial Analyst at Care-Group Health System. Institutional Investor recognized Mr. Larsen as a Rising Star in 2011, 2012 and 2013 for healthcare technology and distribution coverage. In 2015, he was recognized by the Starmine Awards as the #1 earnings predictor for healthcare providers and services. Mr. Larsen earned an MBA in healthcare management and entrepreneurship from Boston University and a BA in economics from Boston College. He is also a member of the CFA Society of Boston.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
CYRX CryoPort	9/18/2025	Boost Price Target	$8.87	$15.00	Buy
EVH Evolent Health	9/9/2025	Reiterated Rating	$9.66	$20.00	Buy
HCAT Health Catalyst	9/5/2025	Reiterated Rating	$3.30		Neutral
VEEV Veeva Systems	8/28/2025	Boost Price Target	$276.66	$340.00	Buy
SLP Simulations Plus	7/7/2025	Lower Price Target	$16.83	$25.00	Buy
CYRX CryoPort	7/7/2025	Lower Price Target	$7.29	$10.00	Buy
DOCS Doximity	6/2/2025	Upgrade	$52.22	$80.00	Buy
PGNY Progyny	3/31/2025	Upgrade	$22.51	$28.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.